Get started
VolitionRX LimitedVolitionRX LimitedVolitionRX Limited

VolitionRX Limited

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

VNRX chart


Full chart

VNRX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪53.83 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.3131 USD
Net income (FY)
‪−26.97 M‬ USD
Revenue (FY)
‪1.23 M‬ USD
Shares float
‪71.49 M‬
Beta (1Y)
1.72

Employees


Employees (FY)
85
Change (1Y)
−25 −22.73%
Revenue / Employee (1Y)
‪14.51 K‬ USD
Net income / Employee (1Y)
‪−317.27 K‬ USD

About VolitionRX Limited


Sector
Health Technology
Industry
Medical Specialties
CEO
Cameron John Reynolds
Website
volition.com
Headquarters
Henderson
Founded
1998
FIGI
BBG000BQWFH2
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

VNRX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as VNRX.

Frequently Asked Questions


The current price of VNRX is 0.5323 USD — it has increased by 3.13% in the past 24 hours. Watch VolitionRX Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange VolitionRX Limited stocks are traded under the ticker VNRX.
VNRX stock has risen by 0.45% compared to the previous week, the month change is a −5.49% fall, over the last year VolitionRX Limited has showed a −29.03% decrease.
We've gathered analysts' opinions on VolitionRX Limited future price: according to them, VNRX price has a max estimate of 5.00 USD and a min estimate of 2.00 USD. Watch VNRX chart and read a more detailed VolitionRX Limited stock forecast: see what analysts think of VolitionRX Limited and suggest that you do with its stocks.
VNRX reached its all-time high on Sep 22, 2014 with the price of 9.2799 USD, and its all-time low was 0.2500 USD and was reached on May 9, 2008. View more price dynamics on VNRX chart.
See other stocks reaching their highest and lowest prices.
VNRX stock is 9.12% volatile and has beta coefficient of 1.72. Track VolitionRX Limited stock price on the chart and check out the list of the most volatile stocks — is VolitionRX Limited there?
Today VolitionRX Limited has the market capitalization of ‪53.83 M‬, it has decreased by −4.00% over the last week.
Yes, you can track VolitionRX Limited financials in yearly and quarterly reports right on TradingView.
VolitionRX Limited is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
VNRX earnings for the last quarter are −0.04 USD per share, whereas the estimation was −0.06 USD resulting in a 18.18% surprise. The estimated earnings for the next quarter are −0.04 USD per share. See more details about VolitionRX Limited earnings.
VolitionRX Limited revenue for the last quarter amounts to ‪190.51 K‬ USD, despite the estimated figure of ‪659.00 K‬ USD. In the next quarter, revenue is expected to reach ‪1.28 M‬ USD.
VNRX net income for the last quarter is ‪−5.79 M‬ USD, while the quarter before that showed ‪−5.82 M‬ USD of net income which accounts for 0.48% change. Track more VolitionRX Limited financial stats to get the full picture.
No, VNRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 5, 2025, the company has 85 employees. See our rating of the largest employees — is VolitionRX Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VolitionRX Limited EBITDA is ‪−25.72 M‬ USD, and current EBITDA margin is ‪−2.09 K‬%. See more stats in VolitionRX Limited financial statements.
Like other stocks, VNRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VolitionRX Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VolitionRX Limited technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VolitionRX Limited stock shows the sell signal. See more of VolitionRX Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.